SCHEMBL14285643

SCHEMBL14285643

O=C(N/N=C/c1cc(Cl)ccc1O)c1ccc(O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 1.00
KMT2A Q03164 6/20 0.81
MEN1 O00255 5/20 0.81
KDM4E B2RXH2 4/20 0.81
RAB9A P51151 3/20 0.81
HTT P42858 3/20 0.81
LMNA P02545 2/20 0.81
SMN1; SMN2 Q16637 2/20 0.81
POLB P06746 2/20 0.81
PSMD14 O00487 1/20 0.81
MMP2 P08253 1/20 0.81
BLM P54132 1/20 0.81
NPC1 O15118 2/20 0.76
MITF O75030 2/20 0.76
GPR174 Q9BXC1 1/20 0.76
L3MBTL1 Q9Y468 1/20 0.76
KLF5 Q13887 1/20 0.66
MAOA P21397 1/20 0.66
MAOB P27338 1/20 0.66
TP53 P04637 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19283330 1.00 KDM1A (1.00) KDM1AKMT2AMEN1KDM4ERAB9A
SCHEMBL6568342 0.94 KDM1A (0.89) KDM1AKMT2AMEN1KDM4ERAB9A
SCHEMBL6568344 0.94 KDM1A (0.89) KDM1AKMT2AMEN1KDM4ERAB9A
SCHEMBL683818 0.94 KDM1A (0.89) KDM1AKMT2AMEN1KDM4ERAB9A
SCHEMBL6751411 0.92 KDM1A (0.85) KDM1AKMT2AMEN1KDM4ERAB9A
SCHEMBL6751409 0.92 KDM1A (0.85) KDM1AKMT2AMEN1KDM4ERAB9A
SCHEMBL684783 0.90 KDM1A (0.82) KDM1AKMT2AMEN1KDM4ERAB9A
SCHEMBL684527 0.89 KDM1A (0.81) KDM1AKMT2AMEN1KDM4ERAB9A
SCHEMBL684542 0.89 KMT2A (1.00) KDM1AKMT2AMEN1KDM4ERAB9A
SCHEMBL684844 0.89 KDM1A (0.80) KDM1AKMT2AMEN1KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2744330-B1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS UNIV UTAH RES FOUND (US) 2020-07-15 EP disclosed
EP-3010915-B1 SUBSTITUTED (3-(5-CHLORO-2-HYDROXYPHENYL)-1-BENZOYL-1H-PYRAZOLE COMPOUNDS AS HISTONE DEMETHYLASE INHIBITORS UNIV UTAH RES FOUND (US) 2019-05-08 EP disclosed
US-20170246130-A1 4-HYDROXYBENZOHYDARZIDE-A NEW CLASS OF ANGIOGENIC ENZYME THYMIDINE PHOSPHORYLASE INHIBITORS CHOUDHARY MUHAMMAD IQBAL (PK) 2017-08-31 US disclosed
US-20170246130-A1 4-HYDROXYBENZOHYDARZIDE-A NEW CLASS OF ANGIOGENIC ENZYME THYMIDINE PHOSPHORYLASE INHIBITORS CHOUDHARY MUHAMMAD IQBAL (PK) 2017-08-31 US disclosed
US-20170246130-A1 4-HYDROXYBENZOHYDARZIDE-A NEW CLASS OF ANGIOGENIC ENZYME THYMIDINE PHOSPHORYLASE INHIBITORS CHOUDHARY MUHAMMAD IQBAL (PK) 2017-08-31 US disclosed
US-9642857-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2017-05-09 US disclosed
US-9642857-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2017-05-09 US disclosed
US-9555024-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2017-01-31 US disclosed
US-9555024-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2017-01-31 US disclosed
US-20160120875-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIV UTAH RES FOUND (US) 2016-05-05 US disclosed
US-20150150864-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2015-06-04 US disclosed
US-20150150864-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2015-06-04 US disclosed
US-8987335-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2015-03-24 US disclosed
US-8987335-B2 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2015-03-24 US disclosed
WO-2014205213-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2014-12-24 WO disclosed
US-20140163017-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIVERSITY OF UTAH (US) 2014-06-12 US disclosed
US-20140163017-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIVERSITY OF UTAH (US) 2014-06-12 US disclosed
WO-2013025805-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2013-02-21 WO disclosed
US-20080015194-A1 METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT Errico, Joseph (US) 2008-01-17 US disclosed
US-20080015194-A1 METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT Errico, Joseph (US) 2008-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150150864-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM1A, DOT1L KDM1A 2/4885KMT2A 25/4885MEN1 3483/4885
US-20140163017-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM1A, DOT1L KDM1A 2/4885KMT2A 25/4885MEN1 3483/4885
US-20080015194-A1 METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT CD74, HAVCR2, CD47 KDM1A 4569/4885KMT2A 4421/4885MEN1 4461/4885
US-20160120875-A1 SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS DOT1L, NSD1, KDM1B KDM1A 7/4885KMT2A 35/4885MEN1 2494/4885
US-20170246130-A1 4-HYDROXYBENZOHYDARZIDE-A NEW CLASS OF ANGIOGENIC ENZYME THYMIDINE PHOSPHORYLASE INHIBITORS TYMP, DPYD, FLT4 KDM1A 732/4885KMT2A 1042/4885MEN1 4714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.